Bristol-Myers Squibb Rights
CELG.RT
18 hedge funds and large institutions have $25.1K invested in Bristol-Myers Squibb Rights in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
18% less funds holding
Funds holding: 22 → 18 (-4)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
98% less capital invested
Capital invested by funds: $1.22M → $25.1K (-$1.2M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$587 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1.21M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$834 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$500 |
| 4 |
TSS
Two Sigma Securities
New York
|
-$377 |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$175 |
CELG.RT Hedge Fund Activity: Q4 2025 in Review
18 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q4 2025, worth a combined $25.1K — down 98% from $1.22M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CELG.RT and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $587. The largest seller was Toronto Dominion Bank, exiting entirely with an estimated $1.21M sold.
- 18 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q4 2025, down from 22 in Q3 2025.
- Funds reported $25.1K of Bristol-Myers Squibb Rights stock for Q4 2025, down 98% quarter-over-quarter.
- 1 fund opened new Bristol-Myers Squibb Rights positions in Q4 2025 and 4 closed out, a net change of -3 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q4 2025 was Virtu Financial, an estimated $587 added.
- The largest Bristol-Myers Squibb Rights seller in Q4 2025 was Toronto Dominion Bank, an estimated $1.21M sold.
Based on aggregated 13F filings for Q4 2025.